3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
There is no vaccine for deadly hantavirus: what that means for future outbreaks
Medical staff arrive to evacuate passengers from MV Hondius, the cruise ship stricken by an outbreak of hantavirus.Credit:…
How some COVID vaccines triggered rare blood-clot disorder
Many countries changed their advice about who should have the AstraZeneca vaccine (pictured) following reports it could trigger…
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
Single antivenom protects against 17 different snakebites
The black mamba is one Africa’s most deadly venomous snakes.Credit: Matthijs Kuijpers/Alamy An antivenom using antibodies from a…
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference London – 14 October 2025 – Purespring…
AI-designed proteins revolutionize gene editing precision and safety
Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life Sciences…
Graves’ Orbitopathy Market to Exhibit Growth at a CAGR of 19.8% During the Forecast Period (2025-2034)
The Graves’ orbitopathy market is undergoing rapid change, driven by advancements in targeted treatments. TEPEZZA (teprotumumab-trbw) remains the…
Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline
Enhanced Genomics (‘Enhanced’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for…
Chronic Gout Market to Witness Strong Growth by 2034 Owing to the Expected Launch of Therapies including mTOR Inhibitors and URAT1 Inhibitors
Key Factors Driving the Growth of the Chronic Gout Market Rising Chronic Gout Prevalence Linked to Lifestyle Changes…